Niki BioSolutions, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingNo share count on file in the XBRL facts for this window.
Newest
$75.0M
S-3 of 2026-08-28. Sales under the at-the-market programme filed with it are not stated apart. S-3 ↗
$75.0M
Agreement of 2026-08-28. No at-the-market sales statement read from a 10-Q or 10-K. S-3 ↗
Warrants
No warrant count read from a 10-Q or 10-K.
Cash
Four quarters of operating cash flow to 2025-12-31 are not all on file.
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2025-10-10 | Public offering | 1,000,000 | $2.00 | $2.0M | 424B5 ↗ |
| 2025-01-02 | Public offering | 1,535,000 | $2.00 | $3.1M | 424B5 ↗ |